TFS192H Datasheet, PDF (1/5 Pages) Vectron International, Inc – VI TELEFILTER Filter specification

Filename: tfs 192h.doc
Vectron International
Version 1.1
Filter specification
Measurement condition
Ambient temperature:
Input power level:
Terminating impedance: *
Input:
Output:
23
°C
0
dBm
430 Ω || -7.1 pF
312 Ω || -9.6 pF
TFS 192H
04.05.2010
1/5
Characteristics
Remark:
The reference level for the relative attenuation arel of the TFS192H is the minimum of the pass band attenuation. This value is defined as the insertion loss
ae. The nominal frequency fN is fixed at 192,0 MHz without any tolerance. The values of relative attenuation arel are guaranteed for the whole operating
temperature range. The frequency shift of the filter in the operating temperature range is included in the production tolerance scheme.
Data
Insertion loss
(reference level)
Nominal frequency
Passband
Pass band ripple
p-p
Relative attenuation
f
N
f ± 100
N
f ± 62
N
f_N ±
33
… f ± 15
N
MHz … f ± 62
N
MHz … f ± 33
N
MHz … f_N ± 22
Operating temperature range
Storage temperature range
Temperature coefficient of frequency
ae
f_N
PB
arel
MHz
MHz
MHz
MHz
OTR
TCf ***
typ. value
10
dB
35
MHz
0,5 dB
0,5 _dB
55
dB
45
dB
10
dB
-96
ppm/K
tolerance / limit
max.
11 dB
192,0 MHz
f_N
±
max.
15 MHz
1,0 dB
max.
min.
min.
min.
1 dB
45 dB**
35 dB
3 dB
- 40 °C ... + 85 °C
- 40 °C ... + 85 °C
-
*) The terminating impedances depend on parasitics and q-values of matching elements and the board used, and are to be understood as reference
values only. Should there be additional questions do not hesitate to ask for an application note or contact our design team.
**) Exceptions for spurious responses possible
***) ∆f(Hz) = TCf(ppm/K) x (T-T₀) x fcat(MHz).
Generated:
Checked / Approved:
Vectron International GmbH & Co. KG
Potsdamer Straße 18
D 14 513 TELTOW / Germany
Tel: [phone] / Fax: [phone]
E-Mail: [e-mail]
Vectron International GmbH & Co. KG reserves the right to make changes to the product(s) and/or information contained herein without
notice. No liability is assumed as a result of their use or application. No rights under any patent accompany the sale of any such
product(s) or information.